Mammary Ductal Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Benign neoplasm of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
17
|
|
0.300 |
None |
|
0 |
|
|
|
Neoplasm of uncertain or unknown behavior of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
17
|
|
0.300 |
None |
|
0 |
|
|
|
Carcinoma in situ of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
19
|
|
0.300 |
None |
|
0 |
|
|
|
Tay-Sachs Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
26
|
129
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Atrial Premature Complexes
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
183
|
21
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Ductal Breast Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
196
|
10
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
296
|
9
|
0.310 |
None |
1.000 |
1 |
|
2013 |
2013 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of gallbladder
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
425
|
81
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mild cognitive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
430
|
96
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Leukemia, T-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
457
|
10
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Mantle cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
466
|
19
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Noninfiltrating Intraductal Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
486
|
13
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Gallbladder Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
498
|
75
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.300 |
None |
|
0 |
|
|
|
Adenomatous Polyposis Coli
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
609
|
237
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Gestational Diabetes
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
649
|
224
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Presenile dementia
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
718
|
159
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |